Scott W. Blume

905 total citations
22 papers, 761 citations indexed

About

Scott W. Blume is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Scott W. Blume has authored 22 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Scott W. Blume's work include RNA Research and Splicing (12 papers), RNA modifications and cancer (10 papers) and RNA and protein synthesis mechanisms (10 papers). Scott W. Blume is often cited by papers focused on RNA Research and Splicing (12 papers), RNA modifications and cancer (10 papers) and RNA and protein synthesis mechanisms (10 papers). Scott W. Blume collaborates with scholars based in United States, South Korea and Germany. Scott W. Blume's co-authors include Richard C. Snyder, Donald M. Miller, Ratna B. Ray, Charles Koller, Steve D. Thomas, Zheng Meng, William E. Grizzle, Christos Vaklavas, Peter D. Emanuel and Nateka L. Jackson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Scott W. Blume

22 papers receiving 754 citations

Peers

Scott W. Blume

ONCOL

IMMUN

GENET

Angelo Lupo Italy

Jeung-Whan Han South Korea

Karen M. Pomeranz United Kingdom

Jarrett T. Whelan United States

Shengyong Yang China

Connie P. Matthews United States

Daniela Di Marcantonio United States

Christin L. Hanigan United States

Elena Cavadini Italy

Laura Di Magno Italy

Angelo Lupo Italy

Scott W. Blume

673 ×1.1

126 ×1.0

199 ×1.7

ONCOL

63 ×1.3

IMMUN

85 ×1.8

GENET

Citations per year, relative to Scott W. Blume Scott W. Blume (= 1×) peers Angelo Lupo

Countries citing papers authored by Scott W. Blume

Since Specialization

Citations

This map shows the geographic impact of Scott W. Blume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Blume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Blume more than expected).

Fields of papers citing papers by Scott W. Blume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott W. Blume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Blume. The network helps show where Scott W. Blume may publish in the future.

Co-authorship network of co-authors of Scott W. Blume

This figure shows the co-authorship network connecting the top 25 collaborators of Scott W. Blume. A scholar is included among the top collaborators of Scott W. Blume based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott W. Blume. Scott W. Blume is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blume, Scott W., et al.. (2023). Novel protein products encoded by upstream open reading frames of the MYCN gene in pediatric embryonal tumors. Journal of Cellular Biochemistry. 124(10). 1615–1627. 1 indexed citations

Vaklavas, Christos, Scott W. Blume, & William E. Grizzle. (2020). Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer. Translational Oncology. 13(2). 452–470. 7 indexed citations

Vaklavas, Christos, Scott W. Blume, & William E. Grizzle. (2017). Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development. Frontiers in Oncology. 7. 158–158. 52 indexed citations

Vaklavas, Christos, et al.. (2016). IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells. Tumor Biology. 37(10). 13247–13264. 12 indexed citations

Vaklavas, Christos, et al.. (2015). Small molecule inhibitors of IRES-mediated translation. Cancer Biology & Therapy. 16(10). 1471–1485. 23 indexed citations

Kim, Seung‐Ki, et al.. (2015). Physiological Expression and Accumulation of the Products of Two Upstream Open Reading Frames mrtl and MycHex1 Along With p64 and p67 Myc From the Human c‐myc Locus. Journal of Cellular Biochemistry. 117(6). 1407–1418. 2 indexed citations

Meng, Zheng, et al.. (2010). The Human IGF1R IRES likely operates through a Shine–Dalgarno‐like interaction with the G961 loop (E‐site) of the 18S rRNA and is kinetically modulated by a naturally polymorphic polyU loop. Journal of Cellular Biochemistry. 110(2). 531–544. 25 indexed citations

Blume, Scott W., et al.. (2010). Northwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES. Experimental and Molecular Pathology. 88(3). 341–352. 8 indexed citations

Meng, Zheng, et al.. (2008). Alterations in RNA‐binding activities of IRES‐regulatory proteins as a mechanism for physiological variability and pathological dysregulation of IGF‐IR translational control in human breast tumor cells. Journal of Cellular Physiology. 217(1). 172–183. 46 indexed citations

10.

Jackson, Nateka L., Denise R. Shaw, Peter D. Emanuel, et al.. (2008). mrtl—A translation/localization regulatory protein encoded within the human c‐myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network. Journal of Cellular Biochemistry. 105(4). 1092–1108. 12 indexed citations

11.

Blume, Scott W.. (2003). Inhibition of tumorigenicity by the 5′-untranslated RNA of the human c-myc P0 transcript. Experimental Cell Research. 288(1). 131–142. 13 indexed citations

12.

Meng, Zheng, et al.. (2003). Evidence for differential ribonucleoprotein complex assembly in vitro on the 5′-untranslated region of the human IGF-IR transcript. Molecular and Cellular Endocrinology. 200(1-2). 127–140. 4 indexed citations

13.

Blume, Scott W., et al.. (2002). The 5′‐untranslated RNA of the human dhfr minor transcript alters transcription pre‐initiation complex assembly at the major (core) promoter. Journal of Cellular Biochemistry. 88(1). 165–180. 32 indexed citations

14.

Kar, Sambit R., Jacob Lebowitz, Scott W. Blume, Kenneth B. Taylor, & Leo M. Hall. (2001). SmtB−DNA and Protein−Protein Interactions in the Formation of the Cyanobacterial Metallothionein Repression Complex: Zn²⁺ Does Not Dissociate the Protein−DNA Complex in Vitro. Biochemistry. 40(44). 13378–13389. 22 indexed citations

15.

Blume, Scott W., Jacob Lebowitz, Wolfgang Zacharias, et al.. (1999). The integral divalent cation within the intermolecular purine*purine{middle dot}pyrimidine structure: a variable determinant of the potential for and characteristics of the triple helical association. Nucleic Acids Research. 27(2). 695–702. 26 indexed citations

16.

Hirsch‐Ernst, Karen Ildico, et al.. (1998). Molecular cDNA Cloning and Tissue Distribution of mRNA Encoding a Novel ATP-Binding Cassette (ABC) Half-Transporter. Biochemical and Biophysical Research Communications. 249(1). 151–155. 15 indexed citations

17.

Gee, Jay E., Scott W. Blume, Richard C. Snyder, Ratna B. Ray, & Donald M. Miller. (1992). Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter.. Journal of Biological Chemistry. 267(16). 11163–11167. 47 indexed citations

18.

Blume, Scott W., Richard C. Snyder, Ratna B. Ray, et al.. (1991). Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.. Journal of Clinical Investigation. 88(5). 1613–1621. 298 indexed citations

19.

Snyder, Richard C., Ratna B. Ray, Scott W. Blume, & Donald M. Miller. (1991). Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry. 30(17). 4290–4297. 103 indexed citations

20.

Miller, Donald M., Scott W. Blume, Matthew P. Borst, et al.. (1990). Oncogenes, Malignant Transformation, and Modern Medicine. The American Journal of the Medical Sciences. 300(1). 59–69. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact